[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335370-105":59,"doc-detail-335370-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","glomus-tumor-of-the-chest-wall-with-metastases-to-lung-case-report-open-access","Glomus Tumor of the Chest Wall With Metastases to Lung - Case Report - Open Access","","Glomus tumors are usually benign soft-tissue neoplasms made of thermoregulatory glomus bodies, while malignant glomus tumors are extremely rare and their pathogenesis, treatment options, and prognosis remain unclear. A 67-year-old woman developed a chest wall glomus tumor with lung metastases confirmed by biopsy. Her management included neoadjuvant radiation followed by pembrolizumab immunotherapy, with imaging showing regression and resolution of lung nodules. Pembrolizumab was stopped due to dermatologic and renal adverse events, and she continues monitoring without ongoing therapy. The case highlights aggressive chest-wall presentation, multi-site lung spread, and a genetic profile with high tumor mutational burden that supported guided treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glomus-tumor-of-the-chest-wall-with-metastases-to-lung-case-report-open-access/335370/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glomus-tumor-of-the-chest-wall-with-metastases-to-lung-case-report-open-access/335370.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are glomus tumors, and how do malignant glomus tumors differ?","Question",{"text":112,"@type":113},"Glomus tumors are typically benign soft-tissue neoplasms composed of thermoregulatory glomus bodies. Malignant glomus tumors are exceptionally rare, with poorly understood pathogenesis, unclear treatment options, and uncertain prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What treatment was used in this case of chest wall glomus tumor with lung metastases?",{"text":117,"@type":113},"The patient received neoadjuvant radiation therapy, followed by immunotherapy with pembrolizumab. Imaging after treatment showed disease regression and resolution of lung nodules.",{"name":119,"@type":110,"acceptedAnswer":120},"Why was pembrolizumab discontinued?",{"text":121,"@type":113},"Pembrolizumab was stopped due to concerns for dermatologic and renal adverse events. The patient continues to be monitored off therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335370,1790177665,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Review began 08/13/2024  \nReview ended 09/08/2024  \nPublished 09/10/2024  \n© Copyright 2024  \nEngle et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.69122  \nOpen Access Case Report  \nGlomus Tumor of the Chest Wall With Metastases to Lung  \nJoshua A. Engle 1 , James T. Dibb 1 , Soumajit Kundu 1, John A. Jakob 2  \n1. Department of Medicine, Summa Health, Akron, USA 2. Department of Medical Oncology, Summa Health, Akron, USA  \nCorresponding author: Joshua A. Engle, [josh.andrew.engle@gmail.com](josh.andrew.engle@gmail.com)  \nAbstract  \nGlomus tumors are typically benign, soft tissue neoplasms composed of thermoregulatory glomus bodies. The more common varieties, such as subungual, are treated surgically and typically have a very low mortality rate. Malignant glomus tumors are very rare, and their pathogenesis is poorly understood. As such, treatment options and prognosis are unclear.  \nWe present a 67-year-old female diagnosed with a chest wall glomus tumor with biopsy-proven metastases to her lungs. Her treatment course included neoadjuvant radiation therapy followed by immunotherapy with pembrolizumab. After completion of the initial radiation therapy, imaging showed disease regression. Interval imaging after seven months of immunotherapy showed the resolution of all lung nodules with no reported concerns for disease recurrence. Pembrolizumab was discontinued due to concerns fordermatologic and renal adverse events, and the patient continues to be monitored off therapy.  \nThe metastatic glomus tumor described in this case had several unique qualities, including its initial presentation on the chest wall as an aggressive lesion, as well as its spread to multiple locations in the lungs. Glomus tumors are not normally as aggressive as seen in this case, but the genetic profile with high tumor mutational burden allowed for guided treatment. Radiation is often used as neoadjuvant treatment in higher risk glomus tumors, but the addition of immunotherapy such as pembrolizumab represents a potential avenue to manage these patients when surgery is not an option.  \nMalignant glomus tumors are exceptionally rare occurrences that, by nature of their rarity, require protocols or therapies that are not specifically designed for their treatment. The clinical course of these tumors is difficult to predict as most cases of metastatic spread have few examples from which to draw conclusions. This case provided encouraging results for treatment with radiation and, potentially, immunotherapy. Each instance of a malignant glomus tumor and its genetic profile should be closely examined and documented so that sufficient data can be accumulated to guide treatment for this rare cancer.  \nCategories: Internal Medicine, Dermatology, Oncology  \nKeywords: soft tissue neoplasm, neuroendocrine tumor, dermatology, lung metastasis, dermato-pathology, oncology, glomus tumor  \nIntroduction  \nGlomus tumors are typically benign mesenchymal neoplasms that make up less than 2% of soft tissue tumors. They are composed of glomus bodies, which are specialized arteriovenous anastomoses in the dermis responsible for thermoregulation. Glomus tumors most commonly arise in the subungual regions of the digits or in the deep dermis of the upper and lower extremities, though they have been described to manifest in several other locations where glomus bodies do not characteristically occur, including themediastinum, bone, penis, and internal organs such as the stomach, small bowel, and lung. A subungual manifestation is more common in women, though there is no clear sex predisposition seen for other sites of disease [1] .  \nMalignant glomus tumors, also known as glomangiosarcomas, are exceptionally rare [2] . The development of malignant potential is p","cbCairN0xMnpNMCM","https://ap.wps.com/l/cbCairN0xMnpNMCM","pdf",9385174,"English","# Abstract\n## Case presentation and treatment course\n## Clinical significance and genetic-guided therapy","[{\"question\":\"What are glomus tumors, and how do malignant glomus tumors differ?\",\"answer\":\"Glomus tumors are typically benign soft-tissue neoplasms composed of thermoregulatory glomus bodies. Malignant glomus tumors are exceptionally rare, with poorly understood pathogenesis, unclear treatment options, and uncertain prognosis.\"},{\"question\":\"What treatment was used in this case of chest wall glomus tumor with lung metastases?\",\"answer\":\"The patient received neoadjuvant radiation therapy, followed by immunotherapy with pembrolizumab. Imaging after treatment showed disease regression and resolution of lung nodules.\"},{\"question\":\"Why was pembrolizumab discontinued?\",\"answer\":\"Pembrolizumab was stopped due to concerns for dermatologic and renal adverse events. The patient continues to be monitored off therapy.\"}]","Glomus Tumor of the Chest Wall With Metastases to Lung - Case Report - Open Access | PDF",1790010721,25]